Evome Medical Technologies Inc. (TSXV:EVMT)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
TSXV:EVMT Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Feb '22 Feb 28, 2022 | Dec '21 Dec 31, 2021 | Feb '21 Feb 28, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1.41 | 0.92 | 1.93 | 8.06 | 4.47 | 7.08 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 0.49 | Upgrade
|
| Cash & Short-Term Investments | 1.41 | 0.92 | 1.93 | 8.06 | 4.47 | 7.57 | Upgrade
|
| Cash Growth | 34.25% | -52.36% | -76.06% | 80.40% | -41.00% | -9.34% | Upgrade
|
| Accounts Receivable | 4.72 | 7.8 | 6.35 | 6.36 | 6.1 | - | Upgrade
|
| Other Receivables | - | - | - | 0.23 | - | - | Upgrade
|
| Receivables | 4.72 | 7.8 | 6.35 | 6.6 | 6.1 | - | Upgrade
|
| Inventory | 9.26 | 10.24 | 8.1 | 4.97 | 5.03 | - | Upgrade
|
| Prepaid Expenses | 2.02 | 2.04 | 0.22 | 0.41 | 0.1 | 0.14 | Upgrade
|
| Restricted Cash | - | - | - | - | - | 5.43 | Upgrade
|
| Total Current Assets | 17.42 | 21 | 16.6 | 20.04 | 15.71 | 13.13 | Upgrade
|
| Property, Plant & Equipment | 9.12 | 13.06 | 11.18 | 5.4 | 5.49 | - | Upgrade
|
| Goodwill | 4.96 | 6.4 | 13.7 | 9.83 | 14.83 | - | Upgrade
|
| Other Intangible Assets | 2.84 | 7.03 | 9.38 | 6.93 | 7.03 | - | Upgrade
|
| Long-Term Accounts Receivable | - | - | 0.19 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.8 | 0.77 | 1.01 | 0.48 | 0.48 | - | Upgrade
|
| Total Assets | 35.13 | 48.26 | 52.05 | 42.68 | 43.54 | 13.13 | Upgrade
|
| Accounts Payable | 6.02 | 6.91 | 5.27 | 2.86 | 2.67 | 0.48 | Upgrade
|
| Accrued Expenses | 1.8 | 1.75 | 1.37 | 0.82 | 0.18 | 0.57 | Upgrade
|
| Short-Term Debt | 3.96 | 6.11 | 5.16 | 5.5 | 5.05 | - | Upgrade
|
| Current Portion of Long-Term Debt | 7.99 | 10.41 | 0.2 | 0.17 | 0.17 | - | Upgrade
|
| Current Portion of Leases | 0.82 | 1.48 | 0.85 | 0.25 | 0.22 | - | Upgrade
|
| Other Current Liabilities | 13.27 | 10.9 | 17.31 | 13.56 | 19.89 | 5.44 | Upgrade
|
| Total Current Liabilities | 33.86 | 37.57 | 30.16 | 23.16 | 28.18 | 6.49 | Upgrade
|
| Long-Term Debt | 0.46 | 0.26 | 0.57 | 0.68 | 0.71 | - | Upgrade
|
| Long-Term Leases | 4.23 | 6.43 | 5.98 | 3.93 | 3.99 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 1.76 | 1.9 | - | Upgrade
|
| Total Liabilities | 38.56 | 44.25 | 36.72 | 29.53 | 34.78 | 6.49 | Upgrade
|
| Common Stock | 53.91 | 53.51 | 40.57 | 38.53 | 37.03 | 31.07 | Upgrade
|
| Additional Paid-In Capital | 9.08 | 9.74 | 8.07 | 6.99 | 4.33 | 3.63 | Upgrade
|
| Retained Earnings | -72.58 | -64.86 | -49.26 | -33.36 | -33.15 | -28.99 | Upgrade
|
| Comprehensive Income & Other | 6.16 | 5.62 | 15.95 | 1.01 | 0.55 | 0.94 | Upgrade
|
| Shareholders' Equity | -3.43 | 4 | 15.33 | 13.15 | 8.76 | 6.64 | Upgrade
|
| Total Liabilities & Equity | 35.13 | 48.26 | 52.05 | 42.68 | 43.54 | 13.13 | Upgrade
|
| Total Debt | 17.47 | 24.69 | 12.76 | 10.53 | 10.15 | - | Upgrade
|
| Net Cash (Debt) | -16.05 | -23.77 | -10.83 | -2.48 | -5.68 | 7.57 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | -9.34% | Upgrade
|
| Net Cash Per Share | -0.18 | -0.32 | -0.20 | -0.06 | -0.13 | 0.22 | Upgrade
|
| Filing Date Shares Outstanding | 82.63 | 78.89 | 69.87 | 54.35 | 42.81 | 33.81 | Upgrade
|
| Total Common Shares Outstanding | 82.63 | 79.89 | 57.11 | 53.89 | 42.81 | 33.81 | Upgrade
|
| Working Capital | -16.44 | -16.57 | -13.56 | -3.12 | -12.47 | 6.64 | Upgrade
|
| Book Value Per Share | -0.04 | 0.05 | 0.27 | 0.24 | 0.20 | 0.20 | Upgrade
|
| Tangible Book Value | -11.22 | -9.42 | -7.74 | -3.61 | -13.1 | 6.64 | Upgrade
|
| Tangible Book Value Per Share | -0.14 | -0.12 | -0.14 | -0.07 | -0.31 | 0.20 | Upgrade
|
| Machinery | 4.16 | 4.43 | 3.71 | 1.53 | 1.52 | - | Upgrade
|
| Leasehold Improvements | 0.34 | 0.56 | 0.15 | 0.13 | 0.13 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.